{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:02:33Z","timestamp":1780761753896,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mucinous gastric adenocarcinoma (MGC) is a rare, aggressive malignancy. This study aimed to explore whether MGC is associated with poorer survival compared with nonmucinous gastric adenocarcinoma (NMGC) and to further investigate the potential impact of neoadjuvant chemotherapy (NAC) on MGC by assessing overall survival (OS), tumor regression grade (TRG), and histological subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 492 patients with MGC and 7945 patients with NMGC undergoing resection at Zhejiang Cancer Hospital (2014\u20132023). Patients were categorized into neoadjuvant and surgery groups. MGC was further classified as pure (\u2265 80%) or mixed (&lt; 80%). OS was analyzed using Kaplan\u2013Meier and Cox regression, with propensity score matching (PSM) for adjustment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After PSM, OS did not differ between MGC and NMGC. Patients with MGC receiving NAC had significantly worse OS than those undergoing surgery, with NAC as an independent risk factor. TRG analysis showed a markedly lower proportion of responders (TRG 0\u20131) in MGC than NMGC, indicating reduced chemosensitivity. Among subtypes, NAC remained an adverse factor in pure MGC, while mixed MGC showed no significant difference after PSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MGC exhibits poor pathological response and no survival benefit from NAC, supporting upfront surgery as the preferred approach. TRG findings highlight intrinsic chemoresistance, particularly in pure MGC, underscoring the need for histology-based individualized strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-19069-9","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T23:16:14Z","timestamp":1777245374000},"page":"6572-6586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Neoadjuvant Chemotherapy on Prognosis of Patients with Mucinous Gastric Adenocarcinoma: A Propensity Score Matching Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Yiming","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"19069_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin."},{"key":"19069_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31\u201349. https:\/\/doi.org\/10.1111\/apm.1965.64.1.31.","journal-title":"Acta Pathol Microbiol Scand."},{"issue":"2","key":"19069_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138. https:\/\/doi.org\/10.1111\/his.13975.","journal-title":"Histopathology."},{"issue":"2","key":"19069_CR4","first-page":"813","volume":"11","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Chen Z, Chen J, et al. Mucinous gastric carcinoma: an update of clinicopathologic features and prognostic value from a retrospective study of clinical series. Int J Clin Exp Path. 2018;11(2):813\u201321.","journal-title":"Int J Clin Exp Path."},{"issue":"4","key":"19069_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2739\/kurumemedj.43.289","volume":"43","author":"K Koufuji","year":"1996","unstructured":"Koufuji K, Takeda J, Toyonaga A, et al. Mucinous adenocarcinoma of the stomach-clinicopathological studies. Kurume Med J. 1996;43(4):289\u201394. https:\/\/doi.org\/10.2739\/kurumemedj.43.289.","journal-title":"Kurume Med J."},{"issue":"6","key":"19069_CR6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1245\/ASO.2006.03.077","volume":"13","author":"C Kunisaki","year":"2006","unstructured":"Kunisaki C, Akiyama H, Nomura M, et al. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma. Ann Surg Oncol. 2006;13(6):836\u201342. https:\/\/doi.org\/10.1245\/ASO.2006.03.077.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19069_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/mco.2014.447","volume":"3","author":"T Isobe","year":"2015","unstructured":"Isobe T, Hashimoto K, Kizaki J, et al. Characteristics and prognosis of mucinous gastric carcinoma. Mol Clin Oncol. 2015;3(1):44\u201350. https:\/\/doi.org\/10.3892\/mco.2014.447.","journal-title":"Mol Clin Oncol."},{"issue":"6","key":"19069_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4166\/kjg.2020.098","volume":"76","author":"H Ahn","year":"2020","unstructured":"Ahn H, Chung WC, Kim YJ, Ryu S, Lim E. Clinical outcomes of mucinous gastric carcinomas compared with non-mucinous and signet ring cell carcinomas. Korean J Gastroenterol. 2020;76(6):297\u2013303. https:\/\/doi.org\/10.4166\/kjg.2020.098.","journal-title":"Korean J Gastroenterol."},{"issue":"6","key":"19069_CR9","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.21873\/anticanres.16456","volume":"43","author":"K Komori","year":"2023","unstructured":"Komori K, Kano K, Ando S, et al. Clinicopathological characteristics and prognosis of mucinous gastric cancer. Anticancer Res. 2023;43(6):2865\u201371. https:\/\/doi.org\/10.21873\/anticanres.16456.","journal-title":"Anticancer Res."},{"issue":"2","key":"19069_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/pl00011728","volume":"4","author":"H Kawamura","year":"2001","unstructured":"Kawamura H, Kondo Y, Osawa S, et al. A clinicopathologic study of mucinous adenocarcinoma of the stomach. Gastric Cancer. 2001;4(2):83\u20136. https:\/\/doi.org\/10.1007\/pl00011728.","journal-title":"Gastric Cancer"},{"issue":"4","key":"19069_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11605-015-3064-0","volume":"20","author":"X Tang","year":"2016","unstructured":"Tang X, Zhang J, Che X, Lan Z, Chen Y, Wang C. The clinicopathological features and long-term survival outcomes of mucinous gastric carcinoma: a consecutive series of 244 cases from a single institute. J Gastrointest Surg. 2016;20(4):693\u20139. https:\/\/doi.org\/10.1007\/s11605-015-3064-0.","journal-title":"J Gastrointest Surg"},{"issue":"Pt A","key":"19069_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijsu.2015.08.081","volume":"23","author":"KM Madbouly","year":"2015","unstructured":"Madbouly KM, Mashhour AN, Omar W. Is it safe to omit neoadjuvant chemo-radiation in mucinous rectal carcinoma? Int J Surg (Lond Engl). 2015;23(Pt A):120\u20137. https:\/\/doi.org\/10.1016\/j.ijsu.2015.08.081.","journal-title":"Int J Surg (Lond Engl)."},{"key":"19069_CR13","doi-asserted-by":"publisher","unstructured":"Sun Y wu, Chi P, Lin H ming, et al. Effect of neoadjuvant chemoradiotherapy on locally advanced rectal mucinous adenocarcinoma: a propensity score-matched study. Gastroenterol Res Pract. 2017;2017:5715219. https:\/\/doi.org\/10.1155\/2017\/5715219","DOI":"10.1155\/2017\/5715219"},{"key":"19069_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejca.2022.04.026","volume":"170","author":"DHW Liu","year":"2022","unstructured":"Liu DHW, \u0160ef\u010dovi\u010dov\u00e1 N, Emmerson J, et al. Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: post-hoc analysis of the UK MRC OE02 and OE05 trials. Eur J Cancer. 2022;170:140\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2022.04.026.","journal-title":"Eur J Cancer."},{"key":"19069_CR15","doi-asserted-by":"publisher","unstructured":"Meng NL, Wang Y kun, Wang HL, Zhou JL, Wang S nan. Research on the histological features and pathological types of gastric adenocarcinoma with mucinous differentiation. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2022.829702","DOI":"10.3389\/fmed.2022.829702"},{"issue":"2","key":"19069_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jnci\/djae227","volume":"117","author":"IA Caspers","year":"2025","unstructured":"Caspers IA, Slagter AE, Vissers PAJ, et al. Histopathological response to chemotherapy and survival of mucinous type gastric cancer. J Natl Cancer Inst. 2025;117(2):253\u201361. https:\/\/doi.org\/10.1093\/jnci\/djae227.","journal-title":"J Natl Cancer Inst."},{"issue":"4","key":"19069_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10120-022-01295-9","volume":"25","author":"JE Lee","year":"2022","unstructured":"Lee JE, Choi YY, An JY, Kim KT, Shin SJ, Cheong JH. Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma. Gastric Cancer. 2022;25(4):697\u2013711. https:\/\/doi.org\/10.1007\/s10120-022-01295-9.","journal-title":"Gastric Cancer."},{"issue":"36","key":"19069_CR18","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.3748\/wjg.v24.i36.4164","volume":"24","author":"A Kasprzak","year":"2018","unstructured":"Kasprzak A, Siod\u0142a E, Andrzejewska M, et al. Differential expression of mucin 1 and mucin 2 in colorectal cancer. World J Gastroenterol. 2018;24(36):4164\u201377. https:\/\/doi.org\/10.3748\/wjg.v24.i36.4164.","journal-title":"World J Gastroenterol."},{"key":"19069_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.breast.2020.07.010","volume":"53","author":"K Lu","year":"2020","unstructured":"Lu K, Wang X, Zhang W, et al. Clinicopathological and genomic features of breast mucinous carcinoma. Breast (Edinb Scotl). 2020;53:130\u20137. https:\/\/doi.org\/10.1016\/j.breast.2020.07.010.","journal-title":"Breast (Edinb Scotl)."},{"issue":"1","key":"19069_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40880-019-0361-0","volume":"39","author":"C Luo","year":"2019","unstructured":"Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond Engl). 2019;39(1):13. https:\/\/doi.org\/10.1186\/s40880-019-0361-0.","journal-title":"Cancer Commun (Lond Engl)."},{"issue":"1","key":"19069_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cjp2.1","volume":"1","author":"N Hugen","year":"2015","unstructured":"Hugen N, Simons M, Halilovi\u0107 A, et al. The molecular background of mucinous carcinoma beyond MUC2. J Pathol Clin Res. 2015;1(1):3\u201317. https:\/\/doi.org\/10.1002\/cjp2.1.","journal-title":"J Pathol Clin Res."},{"issue":"6","key":"19069_CR22","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/cancers13061389","volume":"13","author":"E O\u2019Connell","year":"2021","unstructured":"O\u2019Connell E, Reynolds IS, McNamara DA, Burke JP, Prehn JHM. Resistance to cell death in mucinous colorectal cancer-a review. Cancers. 2021;13(6):1389. https:\/\/doi.org\/10.3390\/cancers13061389.","journal-title":"Cancers."},{"issue":"6","key":"19069_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306058","volume":"19","author":"H Kishimoto","year":"2024","unstructured":"Kishimoto H, Ridley C, Inoue K, Thornton DJ. Assessment of polymeric mucin-drug interactions. PLoS ONE. 2024;19(6):e0306058. https:\/\/doi.org\/10.1371\/journal.pone.0306058.","journal-title":"PLoS ONE."},{"issue":"3","key":"19069_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41397-019-0137-6","volume":"20","author":"IS Reynolds","year":"2020","unstructured":"Reynolds IS, O\u2019Connell E, Fichtner M, et al. Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer. Pharmacogenomics J. 2020;20(3):524\u201332. https:\/\/doi.org\/10.1038\/s41397-019-0137-6.","journal-title":"Pharmacogenomics J."},{"key":"19069_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS17-P1-01-13","author":"A Astashchanka","year":"2018","unstructured":"Astashchanka A, Shroka TM, Jacobsen B. Abstract P1\u201301-13: mucin-2 (muc-2) modulates the biology of breast cancer. Cancer Res. 2018. https:\/\/doi.org\/10.1158\/1538-7445.SABCS17-P1-01-13.","journal-title":"Cancer Res."},{"issue":"63","key":"19069_CR26","doi-asserted-by":"publisher","first-page":"106888","DOI":"10.18632\/oncotarget.22455","volume":"8","author":"AK Dilly","year":"2017","unstructured":"Dilly AK, Honick BD, Lee YJ, et al. Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei. Oncotarget. 2017;8(63):106888\u2013900. https:\/\/doi.org\/10.18632\/oncotarget.22455.","journal-title":"Oncotarget."},{"issue":"10","key":"19069_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nri.2016.88","volume":"16","author":"MEV Johansson","year":"2016","unstructured":"Johansson MEV, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol. 2016;16(10):639\u201349. https:\/\/doi.org\/10.1038\/nri.2016.88.","journal-title":"Nat Rev Immunol."},{"key":"19069_CR28","doi-asserted-by":"publisher","first-page":"1500374","DOI":"10.3389\/fimmu.2024.1500374","volume":"15","author":"CM Raynaud","year":"2024","unstructured":"Raynaud CM, Jabeen A, Ahmed EI, et al. MUC2 expression modulates immune infiltration in colorectal cancer. Front Immunol. 2024;15:1500374. https:\/\/doi.org\/10.3389\/fimmu.2024.1500374.","journal-title":"Front Immunol."},{"issue":"1","key":"19069_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320. https:\/\/doi.org\/10.1056\/NEJMoa055531.","journal-title":"N Engl J Med."},{"key":"19069_CR30","doi-asserted-by":"publisher","unstructured":"Messager M, Lefevre JH, Pichot-Delahaye V, et al. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011;254(5):684-693; discussion 693. https:\/\/doi.org\/10.1097\/SLA.0b013e3182352647","DOI":"10.1097\/SLA.0b013e3182352647"},{"key":"19069_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04441-w","author":"FJ Hu","year":"2023","unstructured":"Hu FJ, Li YJ, Zhang L, et al. Single-cell profiling reveals differences between human classical adenocarcinoma and mucinous adenocarcinoma. Commun Biol. 2023. https:\/\/doi.org\/10.1038\/s42003-023-04441-w.","journal-title":"Commun Biol."},{"key":"19069_CR32","doi-asserted-by":"publisher","DOI":"10.69950\/jhc.2024.v8.i2.5","author":"S Sultana","year":"2024","unstructured":"Sultana S, Islam N, Kabir E. Correlation of ki-67 proliferating index with histological types and characterization of mucin in colorectal carcinoma. J Histopathol Cytopathol. 2024. https:\/\/doi.org\/10.69950\/jhc.2024.v8.i2.5.","journal-title":"J Histopathol Cytopathol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19069-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:34Z","timestamp":1780761094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19069-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["19069"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19069-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest or financial ties to disclose from the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}